Regulation of the ADMA-DDAH system in endothelial cells: a novel mechanism for the sterol response element binding proteins, SREBP1c and -2. (Q33589158)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Regulation of the ADMA-DDAH system in endothelial cells: a novel mechanism for the sterol response element binding proteins, SREBP1c and -2.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

28 July 2017

Regulation of the ADMA-DDAH system in endothelial cells: a novel mechanism for the sterol response element binding proteins, SREBP1c and -2. (English)

1 reference

Europe PubMed Central

28 July 2017

0 references

object named as

James Leiper

4

0 references

Patrick Vallance

5

object named as

Patrick Vallance

1 reference

Europe PubMed Central

28 July 2017

author name string

Christine Y Ivashchenko

1

1 reference

Europe PubMed Central

28 July 2017

Benjamin T Bradley

2

1 reference

Europe PubMed Central

28 July 2017

Zhaohui Ao

3

1 reference

Europe PubMed Central

28 July 2017

Douglas G Johns

6

1 reference

Europe PubMed Central

28 July 2017

publication date

13 November 2009

1 reference

Europe PubMed Central

28 July 2017

American Journal of Physiology Heart and Circulatory Physiology

1 reference

Europe PubMed Central

28 July 2017

298

1 reference

Europe PubMed Central

28 July 2017

H251-8

1 reference

Europe PubMed Central

28 July 2017

1

1 reference

Europe PubMed Central

28 July 2017

Asymmetric dimethylarginine: a novel marker of risk and a potential target for therapy in chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Selective binding of sterol regulatory element-binding protein isoforms and co-regulatory proteins to promoters for lipid metabolic genes in liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Dimethylarginine dimethylaminohydrolase overexpression enhances insulin sensitivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Detrimental effect of oxidized LDL on endothelial arginine metabolism and transportation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Effects of atorvastatin on the different phases of atherogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine predict adverse events in patients undergoing noncardiac surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Asymmetric dimethylarginine, smoking, and risk of coronary heart disease in apparently healthy men: prospective analysis from the population-based Monitoring of Trends and Determinants in Cardiovascular Disease/Kooperative Gesundheitsforschung in de

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Disruption of methylarginine metabolism impairs vascular homeostasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Farnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Simvastatin treatment improves endothelial function and increases fibrinolysis in patients with hypercholestrolemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Dimethylarginine dimethylaminohydrolase 2 increases vascular endothelial growth factor expression through Sp1 transcription factor in endothelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

ADMA metabolism and clearance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Dimethylarginine dimethylaminohydrolase overexpression suppresses graft coronary artery disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

NO and angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

The DDAH/ADMA/NOS pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Common genetic variation in a basal promoter element alters DDAH2 expression in endothelial cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Endothelial dysfunction: a marker of atherosclerotic risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

all-trans-Retinoic acid increases nitric oxide synthesis by endothelial cells: a role for the induction of dimethylarginine dimethylaminohydrolase.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Does ADMA cause endothelial dysfunction?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Biological significance of endogenous methylarginines that inhibit nitric oxide synthases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Nitric oxide: physiology, pathophysiology, and pharmacology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

21 June 2018

Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00195.2009

21 January 2018

Statins reduce macrophage inflammatory protein-1alpha expression in human activated monocytes.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00195.2009

21 January 2018

Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00195.2009

21 January 2018

Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00195.2009

21 January 2018

Statin treatment and 3' polyadenylation of eNOS mRNA.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00195.2009

21 January 2018

Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00195.2009

21 January 2018

Early effects of simvastatin versus atorvastatin on oxidative stress and proinflammatory cytokines in hyperlipidemic subjects.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00195.2009

21 January 2018

The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA).

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00195.2009

21 January 2018

Effect of high-dose statin treatment on plasma concentrations of endogenous nitric oxide synthase inhibitors

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00195.2009

21 January 2018

Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00195.2009

21 January 2018

Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00195.2009

21 January 2018

Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00195.2009

21 January 2018

Simvastatin improves diabetes-induced coronary endothelial dysfunction.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00195.2009

21 January 2018

Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00195.2009

21 January 2018

Macrophage infiltration, lectin-like oxidized-LDL receptor-1, and monocyte chemoattractant protein-1 are reduced by chronic HMG-CoA reductase inhibition

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00195.2009

21 January 2018

Relationship of asymmetric dimethylarginine with flow-mediated dilatation in subjects with newly detected severe hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00195.2009

21 January 2018

Effect of atorvastatin on plasma levels of asymmetric dimethylarginine in patients with non-ischaemic heart failure

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00195.2009

21 January 2018

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00195.2009

21 January 2018

Effect of simvastatin on plasma asymmetric dimethylarginine concentration in patients with chronic kidney disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

31 October 2018

Rosuvastatin prevents endothelial cell death and reduces atherosclerotic lesion formation in ApoE-deficient mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

31 October 2018

HMG-CoA reductase inhibitor stabilizes rabbit atheroma by increasing basal NO and decreasing superoxide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806130

31 October 2018

Angiogenesis is impaired by hypercholesterolemia: role of asymmetric dimethylarginine

1 reference

https://pubmed.ncbi.nlm.nih.gov/19915177

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/19915177

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isoform-specific regulation by N(G),N(G)-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/NO

1 reference

https://pubmed.ncbi.nlm.nih.gov/19915177

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolation and Identification of N,N- and N,N' -Dimethylarginine, Nε-Mono-, Di-, and Trimethyllysine, and Glucosylgalactosyl- and Galactosyl-δ-hydroxylysine from Human Urine

1 reference

https://pubmed.ncbi.nlm.nih.gov/19915177

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/19915177

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Central and peripheral effects of asymmetric dimethylarginine, an endogenous nitric oxide synthetase inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/19915177

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney

1 reference

https://pubmed.ncbi.nlm.nih.gov/19915177

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1152/AJPHEART.00195.2009

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33589158&oldid=2020742721"